Case 40-2006: Anemia and Low HDL Cholesterol
- 3 May 2007
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (18) , 1893-1895
Abstract
In the Case Record of a patient with anemia and a low level of high-density lipoprotein (HDL) cholesterol, presented by Murali and colleagues (Dec. 28 issue),1 the discussant states that on rare occasions the presence of a paraprotein interferes with the measurement of HDL cholesterol, wrongly suggesting a low level. The discussant also states that the low levels of HDL cholesterol were due to genetic factors or were secondary to specific hormones, cigarette smoking, obesity, a low-fat diet, and drugs. Although all these secondary factors are found frequently, the most frequent cause of a low level of HDL cholesterol in hospitalized patients is simply an acute or chronic severe inflammatory disease with a marked acute-phase reaction. Like albumin and transferrin, HDL cholesterol drops and returns to normal within days after the end of the acute-phase reaction. Negative tests for acute-phase proteins are often overlooked as excellent markers of ongoing inflammation, and too often, a low albumin level is immediately regarded as evidence of malnutrition and a low HDL cholesterol level as evidence of a cardiovascular risk factor necessitating intervention. One should remember the complex changes that occur in lipoproteins during the acute-phase reaction in a patient with inflammation or infection.2,3Keywords
This publication has 6 references indexed in Scilit:
- Case 40-2006New England Journal of Medicine, 2006
- Understanding Changes in High Density Lipoproteins During the Acute Phase ResponseArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Artifactual Undetectable HDL-Cholesterol with the Beckman Synchron LX and Vitros 950 Assays Temporally Associated with a ParaproteinClinical Chemistry, 2004
- Acquired HDL Deficiency Associated With Apolipoprotein A-I Reactive Monoclonal ImmunoglobulinsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Statins and the Acute-Phase ResponseNew England Journal of Medicine, 2001
- Infection and Inflammation‐Induced Proatherogenic Changes of LipoproteinsThe Journal of Infectious Diseases, 2000